<qa>  What is the epidermal growth factor receptor status?II. To determine if ZD 1839, given orally on a daily basis starting at the time of conventional radiation therapy RT, may improve the overall survival of adults with newly-diagnosed supratentorial glioblastoma multiforme, compared with historical controls, stratifying by epidermal growth factor receptor EGFR status. 